Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine

Journal of Clinical Psychiatry

Volumn 61, Issue 4, 2000, Pages 276-281

  Kennedy, Sidney H ^a,b   Eisfeld, Beata S ^b   Dickens, Susan E ^b   Bacchiochi, Jason R ^b   Bagby, R Michael ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXEPIN; FLUOXETINE; HYPNOTIC SEDATIVE AGENT; LEVOTHYROXINE; MOCLOBEMIDE; MONOAMINE OXIDASE A INHIBITOR; NEFAZODONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; ORAL CONTRACEPTIVE AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; MALE; ORGASM; PRIORITY JOURNAL; SEX DIFFERENCE; SEXUAL AROUSAL; SEXUAL DYSFUNCTION; SEXUALITY;

EID: 0034069037     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0406     Document Type: Article

References (25)

1. Balon R, Yeragani VK, Pohl R, et al. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993;54:209-212
2. Demyttenaere K, De Fruyt J, Sienaert P. Psychotropics and sexuality. Int Clin Psychopharmacol 1998;13(suppl 6):S35-S41
3. Dorevitch A, Davis H. Fluvoxamine associated sexual dysfunction. Ann Pharmacother 1994;28:872-874
4. Segraves RT. Overview of sexual dysfunction complicating the treatment of depression. J Clin Psychiatry Monograph 1992;10(2):4-10
5. Gitlin MJ. Effects of depression and antidepressants on sexual functioning. Bull Menninger Clin 1995;59:233-248
6. Margolese HC, Assalian P. Sexual side effects of antidepressants: a review. J Sex Marital Ther 1996;22:209-217
7. Segraves RT. Antidepressant-induced sexual dysfunction. J Clin Psychiatry 1998;59(suppl 4):48-54
8. Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1995
9. Compendium of Pharmaceuticals and Specialties. 34th ed. Toronto, Ontario: Canadian Pharmaceutical Association; 1999
10. Feiger A, Kiev A, Shrivastava RK, et al. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual functioning and satisfaction. J Clin Psychiatry 1996;57 (suppl 2):53-62
11. Kavoussi RJ, Segraves RT, Hughes AR, et al. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatry 1997;58:532-537
12. Modell JG, Katholi CR, Modell JD, et al. (1997). Pharmacoepidemiology and drug utilization: comparative sexual side effects of bupropion, fluoxetine, paroxetine and sertraline. Clin Pharmacol Ther 1997;61:476-487
13. Kennedy SH, Ralevski E, Davis C, et al. The effects of modobemide on sexual desire and function in healthy volunteers. Eur Neuropsychopharmacol 1996;6:177-181
14. Baldwin DS. Depression and sexual function. J Psychopharmacol 1996; 10:30-34
15. Kennedy SH, Dickens S, Eisfeld BS, et al. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 1999;56:197-204
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
17. Healy D. Psychiatric Drugs Explained. 2nd ed. London, England: Mosby; 1997
18. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, Version 2.0). New-York, NY: Biometric Research, New York State Psychiatric Institute; 1995
19. Frank E. Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851-855
20. Montejo-Gonzalez AL, Liorca G, Izquierdo JA, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline and fluvoxamine in a prospective multicenter and descriptive clinical study of 344 patients. J Sex Marital Ther 1997;23:176-194
21. Lane RM. A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction: incidence, possible aetiology and implications for management. J Psychopharmacol 1997;11:72-82
22. Waldinger MD, Hengeveld MW, Zwinderman AH, et al. The effects of SSRI antidepressants on ejaculation: a double-blind, randomised, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. J Clin Psychopharmacol 1998;18:274-281
23. Philipp M, Kohnen R, Benkert O. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int Clin Psychopharmacol 1993;7:149-153
24. Bitran D, Hull EM. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev 1987;11:365-389
25. Schweizer E, Feighner J, Mandos LA, et al. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. J Clin Psychiatry 1994;55:104-108